Monday morning (May 23, 2016), the Supreme Court may announce whether it has granted certiorari inDow Chemical Co. v. Nova Chemicals Corp. (Canada), Supr.Ct. No. 15-1160, proceedings below, 803 F.3d 620 (Fed. Cir. 2015)(Dyk, J.).
The Question Presented, in the wake Nautilus, Inc. v. Biosig Instruments, Inc.,134 S.Ct. 2120 (2014), asks “[w]hether factual findings underlying a district court’s determination on the definiteness of a patent claim under the Patent Act, 35 U.S.C. 112, like a district court’s factual findings underlying construction of a patent claim, are subject to appellate review only for clear error or substantial evidence rather than de novo review.”